Mindray's controlling shareholder pledges shares ahead of H-share listing

Shenzhen Mindray Bio-Medical Electronics announced that its controlling shareholder, Magnifice (HK) Limited, pledged 4.4m shares, representing 1.48% of its holdings and 0.36% of the company's total share capital. The pledge, to China Everbright Bank (Hong Kong Branch), is for "other" purposes, with a maturity date linked to the completion of pledge registration procedures. This action coincides with Mindray's board approval to pursue an H-share listing on the Hong Kong Stock Exchange, aiming to enhance capital strength and international strategy.

In preparation for the H-share listing, Mindray also announced the appointment of Ernst & Young (Hong Kong) as its special audit institution, citing their extensive experience in overseas listings. Concurrently, the company is updating its articles of association and various governance policies, including those for external guarantees, related-party transactions, financial derivatives, information disclosure, independent director procedures, remuneration and assessment, internal information reporting, share changes for directors and senior management, and investor relations. These updates align with legal and regulatory requirements in both mainland China and Hong Kong.